Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT06088654 · TERMINATED

Trial details

NCT number: NCT06088654
Sponsor: Innate Pharma
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma

Start date: 2024-03-04
Primary completion: 2026-02-06
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.